Results for tag: "Drug Resistant Bacteria"

The Drug Resistant Bacteria market is a subset of the Antibiotics market, which is focused on the development of treatments for bacteria that have become resistant to existing antibiotics. This market is driven by the need to develop new treatments to combat the growing threat of drug-resistant bacteria, which can cause serious and sometimes fatal infections. Companies in this market are researching and developing new antibiotics, as well as alternative treatments such as vaccines, probiotics, and phage therapy. Additionally, companies are exploring the use of existing antibiotics in combination with other drugs to increase their effectiveness. Companies in the Drug Resistant Bacteria market include Merck & Co., GlaxoSmithKline, Pfizer, Novartis, Sanofi, AstraZeneca, Johnson & Johnson, Bayer, and Eli Lilly. Show Less Read more